ASH 2022: Short-course Brentuximab Vedotin with Chemotherapy is Highly Active in Early-Stage Bulky Hodgkin LymphomaASH 2022 Treatment with short-course brentuximab vedotin (Adcetris; BV), an antibody-drug conjugate, combined with chemotherapy in early-stage, bulky Hodgkin lymphoma (HL) was associated with four-year overall…
Where Are They Now? Deborah Stephens, DO When did you become interested in the study of medicine? In lymphoma specifically? I grew up on a farm, and my mom told me she knew I would go into medicine because I…
A Multi-Layered View to Lymphoma Research Some people are born to be scientists, and Eric D. Hsi, MD, Department Chair of Pathology at Wake Forest University School of Medicine, is one such person. While he may have always known he…
On January 27, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved pirtobrutinib (Jaypirca, Eli Lilly and Company), for relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a BTK inhibitor.…
On January 19, the U.S. Food and Drug Administration (FDA) announced it has approved bruton tyrosine kinase (BTK), zanubrutinib (Brukinsa, BeiGene), for chronic lymphocytic leukemia/ small lymphocytic lymphoma (CLL/SLL). BTK is a protein critical for the growth and survival of B-cells. BTK…
On December 22, 2022, the U.S. Food and Drug Administration (FDA) announced it has approved the use of mosunetuzumab-axgb (Lunsumio, Genentech, Inc.), a bispecific antibody, for the treatment of adult patients with relapsed/refractory follicular lymphoma (FL) after two or more…
December 23, 2022 – It is with great sadness that the Lymphoma Research Foundation (LRF) shares news of the passing of Errol M. Cook, a two-time Chair of the LRF Board of Directors and current Director Emeritus. With his devoted…
No parent should ever have to go through the excruciating experience of losing a child. When Ellen M. Walker lost her only son, Paul, to lymphoma in 2012, she was devastated. She channeled her grief into creating The Paul Foundation…
Roy Bridges has the type of life story you need to read to believe. Starting on a farm in rural northeast Georgia, it includes attending the U.S. Air Force Academy; surviving 226 Vietnam combat missions; serving as a staff officer…